PAION AG (PAIOF)
0.07
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
PAION Net Income (Quarterly)
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2015 | -8.561M |
| September 30, 2015 | -10.06M |
| June 30, 2015 | -7.342M |
| March 31, 2015 | -5.287M |
| December 31, 2014 | -3.457M |
| September 30, 2014 | -3.314M |
| June 30, 2014 | -2.233M |
| March 31, 2014 | -3.024M |
| December 31, 2013 | 1.755M |
| September 30, 2013 | -1.736M |
| June 30, 2013 | -2.007M |
| March 31, 2013 | -0.8622M |
| December 31, 2012 | 0.2101M |
| September 30, 2012 | -0.0388M |
| June 30, 2012 | -2.321M |
| March 31, 2012 | 23.19M |
| December 31, 2011 | -11.62M |
| September 30, 2011 | -3.054M |
| June 30, 2011 | -0.5232M |
| March 31, 2011 | -3.459M |
| December 31, 2010 | -2.625M |
| September 30, 2010 | -3.867M |
| June 30, 2010 | -1.848M |
| March 31, 2010 | -3.967M |
| Date | Value |
|---|---|
| December 31, 2009 | -4.422M |
| September 30, 2009 | -4.507M |
| June 30, 2009 | -4.853M |
| March 31, 2009 | -4.332M |
| December 31, 2008 | -4.294M |
| September 30, 2008 | -3.428M |
| June 30, 2008 | -9.151M |
| March 31, 2008 | -1.764M |
| December 31, 2007 | -5.531M |
| September 30, 2007 | 5.827M |
| June 30, 2007 | -9.125M |
| March 31, 2007 | -5.458M |
| December 31, 2006 | -5.961M |
| September 30, 2006 | -2.528M |
| June 30, 2006 | -6.937M |
| March 31, 2006 | -6.330M |
| December 31, 2005 | -6.934M |
| September 30, 2005 | 10.75M |
| June 30, 2005 | -4.947M |
| March 31, 2005 | -4.992M |
| December 31, 2004 | -6.622M |
| September 30, 2004 | -4.504M |
| June 30, 2004 | 13.00M |
| March 31, 2004 | -2.281M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| CureVac NV | 319.28M |
| Anbio Biotechnology | -- |
| Epigenomics AG | -- |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alkermes Plc | 0.501M |